| Dr John J O'keefe, MD | |
|
4849 W Fullerton Ave, Chicago, IL 60639-2503 | |
| (312) 326-6100 | |
| Not Available |
| Full Name | Dr John J O'keefe |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 45 Years |
| Location | 4849 W Fullerton Ave, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073678942 | NPI | - | NPPES |
| 036061666 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 036061666 (Illinois) | Primary |
| Entity Name | Marian Orthopedic & Rehabilitation Centers, S.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245230747 PECOS PAC ID: 9830129873 Enrollment ID: O20050818000775 |
News Archive
A research team at Uppsala University, Sweden has shown in a new study, published in the journal Acta Zoologica, that the size of the spot on a male collared flycatcher's forehead reflects how well the immune defence system combats viruses such as avian influenza.
Analysts say many in America take jobs they otherwise wouldn't simply for the health insurance coverage, Reuters/Boston Globe reports.
Lexicon Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, $95,000,000 of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. Lexicon also intends to grant the underwriters a 30-day option to purchase up to an additional $14,250,000 of common stock to cover over-allotments, if any.
Health and Human Services Secretary Kathleen Sebelius on Thursday said insurers who blame their rate increases on the new health overhaul could be excluded from health insurance exchanges and the 30 million new customers they promise, The Associated Press reports. "'There will be zero tolerance for this type of misinformation and unjustified rate increases,' … Sebelius said in a letter to the insurance lobby.
Medivation, Inc. and Astellas Pharma Inc. today announced that patient enrollment was completed on November 15, 2010 in the Phase 3 AFFIRM study of the investigational drug MDV3100, a novel, triple-acting oral androgen receptor antagonist, in patients with advanced prostate cancer who have previously been treated with chemotherapy. The companies also announced that clinical development of MDV3100 in Japan has commenced, with the initiation of patient dosing in a Phase 1-2 clinical study.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John J O'keefe, MD 39654 Treasury Ctr, Chicago, IL 60694-9000 Ph: (312) 326-6100 | Dr John J O'keefe, MD 4849 W Fullerton Ave, Chicago, IL 60639-2503 Ph: (312) 326-6100 |
News Archive
A research team at Uppsala University, Sweden has shown in a new study, published in the journal Acta Zoologica, that the size of the spot on a male collared flycatcher's forehead reflects how well the immune defence system combats viruses such as avian influenza.
Analysts say many in America take jobs they otherwise wouldn't simply for the health insurance coverage, Reuters/Boston Globe reports.
Lexicon Pharmaceuticals, Inc. today announced that it is offering to sell, subject to market and other conditions, $95,000,000 of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. Lexicon also intends to grant the underwriters a 30-day option to purchase up to an additional $14,250,000 of common stock to cover over-allotments, if any.
Health and Human Services Secretary Kathleen Sebelius on Thursday said insurers who blame their rate increases on the new health overhaul could be excluded from health insurance exchanges and the 30 million new customers they promise, The Associated Press reports. "'There will be zero tolerance for this type of misinformation and unjustified rate increases,' … Sebelius said in a letter to the insurance lobby.
Medivation, Inc. and Astellas Pharma Inc. today announced that patient enrollment was completed on November 15, 2010 in the Phase 3 AFFIRM study of the investigational drug MDV3100, a novel, triple-acting oral androgen receptor antagonist, in patients with advanced prostate cancer who have previously been treated with chemotherapy. The companies also announced that clinical development of MDV3100 in Japan has commenced, with the initiation of patient dosing in a Phase 1-2 clinical study.
› Verified 2 days ago
Dr. Yi-loong Colin Woon, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1740 W Taylor St, Chicago, IL 60612 Phone: 866-600-2273 | |
Dr. Vehniah Kristin Tjong, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 259 E Erie St, 13th Floor, Chicago, IL 60611 Phone: 312-695-6800 | |
David R Guelich, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3000 Halsted Street, Suite 525, Chicago, IL 60657 Phone: 773-443-3130 | |
Dr. Daniel A Ivankovich, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1044 N Francisco Ave Ste 203, Chicago, IL 60622 Phone: 312-527-6500 Fax: 800-281-6952 | |
Dr. Michael R Treister, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1431 N Western Ave, Chicago, IL 60622 Phone: 312-633-5866 Fax: 312-633-5867 | |
Dr. Adam Isaac Edelstein, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 259 E Erie St Ste 13-205, Chicago, IL 60611 Phone: 312-695-8143 Fax: 312-695-4075 | |
Dr. Ari J Kaz, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2923 N California Ave, Suite 300, Chicago, IL 60618 Phone: 773-777-9900 Fax: 773-777-5927 |